dichlorobis(cyclopentylamine)platinum: RN given refers to unlabeled cpd(SP-4-2)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 91628 |
| MeSH ID | M0058300 |
| Synonym |
|---|
| trans-bis(cyclopentylammine)dichloroplatinum (ii) |
| platinum, dichlorobis(cyclopentanamine)-, (sp-4-2)- |
| einecs 254-125-2 |
| pt-11 |
| cis-dicyclopentylamminedichloroplatinum (ii) |
| platinum (ii), bis(cyclopentylammine)dichloro-, trans- |
| cis-dichlorobis(cyclopentylammine)platinum(ii) |
| dichlorobis(cyclopentylamine)platinum |
| cis-bis(cyclopentylammine)platinum(ii) |
| platinum (ii), bis(cyclopentylammine)dichloro-, cis- |
| 38780-36-8 |
| 56846-69-6 |
| nsc 170898 |
| x4g53v7wuh , |
| unii-x4g53v7wuh |
| cyclopentanamine;platinum(2+);dichloride |
| DTXSID00972273 |
| platinum(2+) chloride--cyclopentanamine (1/2/2) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||